All Comments by

  1. John Hardy on Next-Generation Sequencing: Boldly Going Where No Geneticist...
  2. Paul Coleman on Neurodegenerative basis of age-related cognitive decline.
  3. Henrik Zetterberg on Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis.
  4. Torleif Hard on Amyloid beta-protein dimers rapidly form stable synaptotoxic protofibrils.
  5. Joel Ross on The AD8—Dementia Screen Ready for Prime Time?
  6. luisa Onstead on Peripheral Aβ Seeds CAA and Parenchymal Amyloidosis
  7. Suzanne Tyas on Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia.
  8. Lars Lannfelt on Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease.
  9. Fuyuki Kametani on Gamma-secretase activating protein is a therapeutic target for Alzheimer's disease.
  10. Kiumars Lalezarzadeh on Anesthesia and Cognitive Decline: No Link in Longitudinal Study
  11. Ramona Jean Alexander on The AD8—Dementia Screen Ready for Prime Time?
  12. James Montgomery on The AD8—Dementia Screen Ready for Prime Time?
  13. Markus Britschgi on A gene expression pattern in blood for the early detection of Alzheimer's disease.
  14. Brian Freibaum on Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue.
  15. Peter Davies on Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model.